JP2009544688A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544688A5 JP2009544688A5 JP2009521380A JP2009521380A JP2009544688A5 JP 2009544688 A5 JP2009544688 A5 JP 2009544688A5 JP 2009521380 A JP2009521380 A JP 2009521380A JP 2009521380 A JP2009521380 A JP 2009521380A JP 2009544688 A5 JP2009544688 A5 JP 2009544688A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- polypeptide
- fusion polypeptide
- phospholipase
- ptd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83258406P | 2006-07-24 | 2006-07-24 | |
| PCT/IB2007/003404 WO2008015580A2 (en) | 2006-07-24 | 2007-07-19 | Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544688A JP2009544688A (ja) | 2009-12-17 |
| JP2009544688A5 true JP2009544688A5 (https=) | 2010-08-05 |
Family
ID=38997534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009521380A Pending JP2009544688A (ja) | 2006-07-24 | 2007-07-19 | 虚血性疾患の緩和及び治療のための医薬組成物並びにそれを伝達するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7902154B2 (https=) |
| EP (1) | EP2044108A4 (https=) |
| JP (1) | JP2009544688A (https=) |
| KR (1) | KR101574630B1 (https=) |
| CN (1) | CN101490080A (https=) |
| WO (1) | WO2008015580A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9416383B2 (en) * | 2007-04-27 | 2016-08-16 | University Of North Carolina At Chapel Hill | Method for enhancing catalytic activity of a lipase |
| US7981446B2 (en) * | 2007-11-26 | 2011-07-19 | Forhumantech. Co., Ltd. | Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| CN101612384B (zh) * | 2009-07-23 | 2012-06-20 | 中国人民解放军第二军医大学 | 多肽小分子mlif在制备防治心肌缺血药物中的应用 |
| KR101278221B1 (ko) | 2010-06-01 | 2013-06-24 | 연세대학교 산학협력단 | Ρｔｄ－ｕｑｃｒｂ 융합 폴리펩타이드 및 그를 포함하는 허혈성 질환의 예방 및 치료용 약제학적 조성물 |
| JP6262721B2 (ja) | 2012-05-11 | 2018-01-17 | ジェムバックス アンド カエル カンパニー，リミティド | 敗血症の予防用または治療用の組成物 |
| WO2013167298A1 (en) | 2012-05-11 | 2013-11-14 | Kael-Gemvax Co., Ltd. | Anti-inflammatory peptides and composition comprising the same |
| ES2981865T3 (es) | 2012-07-11 | 2024-10-10 | Gemvax & Kael Co Ltd | Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo |
| WO2014171792A1 (ko) | 2013-04-19 | 2014-10-23 | 주식회사 카엘젬백스 | 허혈성 손상 치료 및 예방용 조성물 |
| RU2677277C2 (ru) | 2013-06-07 | 2019-01-16 | Джемвакс Энд Каэл Ко., Лтд. | Биологические маркеры, которые могут быть использованы в иммунотерапии рака |
| JP6495899B2 (ja) | 2013-06-21 | 2019-04-03 | ジェムバックス アンド カエル カンパニー，リミティド | ホルモン分泌調節剤、及びそれを含む組成物 |
| KR102359396B1 (ko) | 2013-11-22 | 2022-02-08 | 주식회사 젬백스앤카엘 | 혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물 |
| KR102314231B1 (ko) | 2013-12-17 | 2021-10-19 | 주식회사 젬백스앤카엘 | 전립선 암 치료용 조성물 |
| WO2015156649A1 (ko) | 2014-04-11 | 2015-10-15 | 주식회사 젬백스앤카엘 | 섬유증 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물 |
| JP6466971B2 (ja) * | 2014-04-30 | 2019-02-06 | ジェムバックス アンド カエル カンパニー，リミティド | 臓器、組織又は細胞移植用組成物、キット及び移植方法 |
| WO2015170790A1 (ko) * | 2014-05-09 | 2015-11-12 | 주식회사 카엘젬백스 | 허혈성 손상 치료 및 예방용 조성물 |
| KR102413243B1 (ko) | 2014-12-23 | 2022-06-27 | 주식회사 젬백스앤카엘 | 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물 |
| KR102636129B1 (ko) | 2015-02-27 | 2024-02-14 | 주식회사 젬백스앤카엘 | 청력 손상 방어용 펩타이드 및 이를 포함하는 조성물 |
| KR102638286B1 (ko) | 2015-07-02 | 2024-02-20 | 주식회사 젬백스앤카엘 | 항바이러스 활성 효능을 가지는 펩티드 및 이를 포함하는 조성물 |
| US10898540B2 (en) | 2016-04-07 | 2021-01-26 | Gem Vax & KAEL Co., Ltd. | Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same |
| KR20250057224A (ko) | 2023-10-19 | 2025-04-29 | 단국대학교 천안캠퍼스 산학협력단 | Pdrn을 이용한 유치줄기세포를 포함하는 세포치료제 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4085297A (en) | 1996-08-23 | 1998-03-06 | Chiron Corporation | Human polyhomeotic 1(hphl) acts as a tumor suppressor |
| US20030104622A1 (en) | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| GB0103110D0 (en) * | 2000-08-25 | 2001-03-28 | Aventis Pharma Inc | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| KR20030062789A (ko) | 2002-01-19 | 2003-07-28 | 포휴먼텍(주) | 생체분자 전달 펩타이드 ｓｉｍ2-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| KR20030062788A (ko) | 2002-01-19 | 2003-07-28 | 포휴먼텍(주) | 생체분자 전달 펩타이드 ｍｐｈ1-ｂｔｍ 및 이것을포함하는 생명공학제품 |
| KR100591936B1 (ko) | 2002-11-12 | 2006-06-22 | 포휴먼텍(주) | 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용 |
| US7166692B2 (en) * | 2003-03-04 | 2007-01-23 | Canbrex Bio Science Walkersville, Inc. | Intracellular delivery of small molecules, proteins, and nucleic acids |
| JP4879020B2 (ja) | 2003-05-01 | 2012-02-15 | コーネル リサーチ ファウンデイション インコーポレイテッド | 細胞に分子を送達する方法及び担体複合体 |
| US7339042B2 (en) * | 2003-06-09 | 2008-03-04 | University Of Florida Research Foundation, Inc. | Gene delivery to tumors |
| ATE478676T1 (de) | 2005-11-04 | 2010-09-15 | Forhumantech Co Ltd | Verfahren zur abgabe von fusionspolypeptid in eine zelle |
| EP2057195A4 (en) | 2006-08-29 | 2010-05-12 | Forhumantech Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME |
-
2007
- 2007-07-19 EP EP07825623A patent/EP2044108A4/en not_active Withdrawn
- 2007-07-19 CN CNA2007800276518A patent/CN101490080A/zh active Pending
- 2007-07-19 WO PCT/IB2007/003404 patent/WO2008015580A2/en not_active Ceased
- 2007-07-19 KR KR1020097001545A patent/KR101574630B1/ko not_active Expired - Fee Related
- 2007-07-19 JP JP2009521380A patent/JP2009544688A/ja active Pending
- 2007-07-24 US US11/878,431 patent/US7902154B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544688A5 (https=) | ||
| RU2582247C2 (ru) | Ингибиторы апоптоза и их применение | |
| US9707268B2 (en) | Angiotensin type 2 (AT2) receptor agonists and uses thereof | |
| JP3473623B2 (ja) | うっ血性心不全を治療するための、成長ホルモンとインスリン様成長因子との組み合わせ | |
| CN110114065A (zh) | 通过甲状旁腺激素受体刺激进行的骨折靶向性骨再生 | |
| WO2016118577A1 (en) | Thymosin-beta-four fusion proteins | |
| US20200399333A1 (en) | Histatins and method of use thereof | |
| KR101746749B1 (ko) | 뇌졸중-유발된 혈관신생 증진제 및 이의 용도 | |
| EA201791668A1 (ru) | Синтетические конъюгаты апелина с жирной кислотой с улучшенным периодом полураспада | |
| JP2025521751A (ja) | コラーゲンペプチドベースの医薬組成物及びその使用 | |
| CN106063928B (zh) | 一种多肽或其衍生物在治疗高血压性心肌肥厚中的应用 | |
| WO2014059530A1 (en) | Derivatives of collagen-binding hairpin peptides | |
| JP7791593B2 (ja) | 細胞透過性ペプチド変異体およびその用途 | |
| Lee et al. | Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats | |
| WO2019106680A1 (en) | Treatment of an ischemic heart disease | |
| JP2025522281A (ja) | Ｃｎｐ化合物の液体医薬製剤 | |
| JPWO2021229067A5 (https=) | ||
| JPWO2021119756A5 (https=) | ||
| CN107261115B (zh) | Asprosin用于制备治疗缺血性心脏病药物的应用 | |
| US20260085101A1 (en) | Novel platelet derived growth factor peptide mimetic | |
| CN112390877B (zh) | Pedf衍生多肽组合物及其在制备保护肺损伤药物中的应用 | |
| JP2004513059A (ja) | ペプチド産物、方法及び組成物 | |
| JPWO2023170302A5 (https=) | ||
| RU2454425C2 (ru) | Производные метастина и их применение | |
| HK40105081A (zh) | 具有抗微生物活性的胜肽 |